ARTICLE | Company News
Potenza Therapeutics, Astellas deal
April 27, 2015 7:00 AM UTC
Astellas partnered with Potenza to discover and develop immuno-oncology candidates targeting undisclosed immune checkpoint pathways, co-stimulatory signals and regulatory T cells. Astellas also gained...